Reusable Pen Device with Cartridge Replacement for Biopharma Companies

As biologics, peptides, and long-term injectable therapies continue to expand globally, biopharmaceutical companies are placing greater emphasis on drug delivery systems that improve patient adherence, reduce lifecycle costs, and support regulatory compliance.

Among available delivery platforms, reusable pen devices with cartridge replacement systems are emerging as a preferred solution for chronic therapies such as GLP-1 therapy, insulin, and peptide-based biologics.

More importantly, pharmaceutical companies are no longer simply sourcing a device supplier-they are seeking a long-term pen device partner capable of supporting development, manufacturing, regulatory alignment, and commercialization.

reusable pen

Why Biopharma Companies Are Moving Toward Reusable Pen Platforms

Traditional disposable injection systems offer convenience, but they also create challenges:

High recurring manufacturing costs

Increased medical plastic waste

Larger packaging and logistics burden

Limited brand differentiation

Reusable pen systems solve these issues by separating the durable device from the drug container.

Instead of discarding the entire pen after use, patients only replace the cartridge while continuing to use the same pen platform.